The largest database of trusted experimental protocols

Atg7 sirna

Manufactured by GenePharma
Sourced in China

ATG7 siRNA is a short interfering RNA (siRNA) molecule that targets the ATG7 gene. The ATG7 gene is involved in the autophagy process, which is a cellular mechanism for degrading and recycling damaged or unwanted cellular components. The ATG7 siRNA can be used to temporarily suppress the expression of the ATG7 gene, which may be useful for studying the role of autophagy in various biological processes.

Automatically generated - may contain errors

4 protocols using atg7 sirna

1

LIMP-2 Knockdown and Overexpression in HNSCC

Check if the same lab product or an alternative is used in the 5 most similar protocols
For knocking down the expression of LIMP-2, the specific shRNA against LIMP-2 (shLIMP-2) and control shRNA (shCtrl) were constructed and packaged by Ubigene Biosciences (Guangzhou, China). The specific targeting sequence was as follows: shLIMP-2 (mouse): 5’-GGGTCTATGGATGAGGGAA-3’. The 4MOSC2 and SCC7 cells were infected with polybrene and lentiviral supernatant and then screened with 4 μg·mL−1 puromycin (Sigma‒Aldrich, USA). The Protein levels were verified using Western blot.
Full-length mouse LIMP-2 complementary DNA was PCR amplified and cloned into the pcDNA3.1 plasmid vector (Tsingke Biotechnology Co. Ltd., China). β-catenin-siRNA (5ʹ-UACAUCAUUUGUAUUCUGCTT-3ʹ), ATG5-siRNA (5ʹ- GCGGUUGAGGCUCACUUUATT-3ʹ), and ATG7-siRNA (5ʹ-GCUAGAGACGUGACACAUATT-3ʹ) were from GenePharma (Suzhou, China). The mRFP-GFP-LC3 plasmid were kindly donated by Dr. T Yoshimori and distributed by Addgene. All the plasmids were transfected into HNSCC cells using Lipofectamine™ 3000 following protocol (Invitrogen, USA).
+ Open protocol
+ Expand
2

Silencing Key Regulators in Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
p53 siRNA, Parkin siRNA, ATG7 siRNA and the plasmid encoding Parkin were obtained from Genepharma (Shanghai, China). Transfection was performed using Lipofectamine 2000 reagent (Invitrogen) according to the instructions provided by the manufacturer.
+ Open protocol
+ Expand
3

Autophagy Regulation by miR-106a in Macrophages

Check if the same lab product or an alternative is used in the 5 most similar protocols
The miR-106a mimics, miR-106a inhibitor, ATG7 siRNA, ATG16L1 siRNA, and ULK1 siRNA were purchased from GenePharma biotechnology company. To assay luciferase activity, HEK 293T cells were cotransfected with the pmirGLO luciferase constructs (WT or Mut) and miR-106a mimics or miR-106a inhibitor using Lipofectamine 2000 according to the manufacturer’s instruction. For autophagy analysis, THP-1 macrophages were transfected with 50 nM mimic negative control (mimic nc) or miR-106a mimics; inhibitor negative control (inhibitor nc) or miR-106a inhibitor; 50 pmol ATG7 siRNA, ATG16L1 siRNA, or ULK1 siRNA according to the manufacturer’s instructions. Several chemical reagents were also used to treat THP-1 macrophages: a lysosome inhibitor, bafilomycin A1 (100 nM; Baf A1, Selleck); An autophagy inducer, rapamycin (50 μg/ml; Rapa, Solarbio Science & Technology Co.).
+ Open protocol
+ Expand
4

Plasmid Transfection and RNA Interference

Check if the same lab product or an alternative is used in the 5 most similar protocols
For transfection of DNA plasmid, recombinant mCherry-EGFP-LC3 plasmid was transfected into cells using Lipofectamine 3000 reagent (Invitrogen), according to the manufacturer’s instruction. Approximately 1 μg of plasmid with 2 μL P3000 reagent and 2 μL of Lipofectamine 3000 reagent (according to 12-well plate) were separately added into 50 μL of Opti-MEM (Gibco) medium, then mixed together for 10 min at room temperature (RT) and added to cells in culture medium. For RNA interference, MEFs were transfected with Atg7 siRNA or negative control siRNA (GenePharma, Shanghai, China; see Supplementary Table S2 for sequences) via Lipofectamine RNAiMAX reagent (Invitrogen), according to the manufacturer’s instructions. Briefly, ~50 pmol of siRNA and 3 μL of Lipofectamine RNAiMAX reagent (according to 12-well plate) were separately added into 50 μL of Opti-MEM medium, then mixed together for 5 min and transfected into MEFs.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!